Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Groves

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptorG J Freeman, A A Cardoso, V A Boussiotis, et al.
The British Journal of Dermatology|December 2, 2017
British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017K E Harman, D Brown, L S Exton, et al.
Journal of the American Academy of Dermatology|March 26, 2026
The effect of prior treatment with intravenous immunoglobulin on rituximab pharmacokinetics and treatment outcomes in pemphigusS Youn, V Naidu, A Yalcinkaya, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptorG J Freeman, A A Cardoso, V A Boussiotis, et al.
The British Journal of Dermatology|December 2, 2017
British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017K E Harman, D Brown, L S Exton, et al.
Journal of the American Academy of Dermatology|March 26, 2026
The effect of prior treatment with intravenous immunoglobulin on rituximab pharmacokinetics and treatment outcomes in pemphigusS Youn, V Naidu, A Yalcinkaya, et al.
Pageof 7